Let's talk medical research

Nina Beaty is an artist and an art therapist. In 2014, a diagnosis of small-cell lung cancer (SCLC) with a short life expectancy turned her life upside down. When her cancer didn't respond to standard treatment, she enrolled in an immunotherapy trial. Four years out, Nina has no evidence of cancer.

The National Infusion Center Association (NICA) is an Austin-based advocacy organization dedicated to improving patient access to in-office infusions. We caught up with Brian Nyquist, NICA’s Executive Director, to talk about the work they’re doing to achieve this goal, and why research studies remain critical to providing optimal patient care.

A New Way to Find and Take Part in Headache Research At Antidote, we’re dedicated to connecting patients with medical research to accelerate the pace discovery of better treatments — and even cures. That’s why we’re excited to announce a new partnership with the National Headache Foundation, an organization on a mission to create a world without headache through awareness, advocacy, education, ...

Our Chief Development Officer, Tom Krohn, is a pharma veteran with deep experience in R&D innovation. He was recently interviewed for an interesting article in Pharma Times on the future of digital health. Now, we’re following up with some additional thoughts from Tom on where digital health is heading, who’s leading the way, and advice he has for the industry.

In the busy and often resource-constrained world of nonprofits, keeping your blog content fresh may seem like the last thing that needs to be on your list. But the fact is, blogging is a great way to engage your audience, allowing you to showcase your organization’s accomplishments while building a trusting relationship with your community, gaining free publicity, and driving traffic to your ...

Today, liver disease affects 30 million people in the US — one in 10 Americans. And unfortunately, that number is on the rise. To address this head-on, more research is required. And of course, that involves more clinical trial volunteers.

On February 9, you may have heard that Congress renewed funding for the Special Diabetes Program (SDP), a key program that funds diabetes research through the National Institutes of Health (NIH). Our friends at JDRF were heavily involved in advocating for the SDP to be renewed, so we sat down with Cynthia Rice, JDRF’s Senior Vice President of Advocacy and Policy, to learn more.

If you’ve been diagnosed with an illness, you probably know the accompanying feeling of uncertainty all too well. How will this impact your life? What treatment will you select? Will there be side effects? Will it work?

We’ve long followed the Scrip Awards - where the industry’s highest achievers are recognized for outstanding work across the drug development spectrum. And now, we’re thrilled to announce that Antidote has been named a Scrip Awards finalist in two different categories: “Best Technological Development in Clinical Trials,” for our product Antidote Match, and “Community Partnership of the Year” for ...

It’s been an exciting fall here at Antidote. We announced our latest round of funding, grew our partner network to more than 210 partners, and are now finalists for two Scrip Awards. The Scrip Awards provide the industry with the opportunity to recognize its highest achievers across the drug development spectrum— from novel deals, to new drug launches, to technological breakthroughs in clinical ...